IMMUNIC, INC. - 8-K Filing

Immunic updated investor presentation on its website with forward-looking statements about clinical trials and business strategy (Items: 7.01 Regulation FD Disclosure On July 14, 2026, Immunic, Inc, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $IMUX

Read the full article at SEC EDGAR

More Regulatory news